Previous 10 | Next 10 |
3 Penny Stocks That Exploded During Trading Today If you’re looking for the best penny stocks to buy, there are hundreds to choose from. And after several days of bearish market trading, we are seeing some penny stocks with explosive gains right now. Although it is hard and n...
Gainers: Sidus Space (SIDU) +94%. Evoke Pharma (EVOK) +50%. Visionary Education Technology Holdings (VEDU) +37%. Heliogen (HLGN) +27%. Ribbon Communications (RBBN) +25%. Digital World Acquisition (DWACW) +22%. Wheels Up Experience (UP) +21%. Austin Gold (AUST) +21%. AeroClean Technologies (AE...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Robinhood ( HOOD ) is falling alongside a new analyst rating. This comes from Atlantic Equities analyst John Heagerty. He dropped the stock to “underweight” with a $5 price target. Source: mund...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Evoke Pharma ( EVOK ) stock is taking off on GIMOTI nasal spray news. It’s been approved for the Florida Medicaid Preferred Drug List. This has EVOK seeing heavy trading today. Source: Alliance Images...
Gainers: Evoke Pharma EVOK +52%. Zynerba Pharmaceuticals (ZYNE) +18%. LifeMD (LFMD) +13%. Vivos Therapeutics (VVOS) +12%. ACADIA Pharmaceuticals ACAD +11%. Losers: 180 Life Sciences (ATNF) -31%. Belite Bio (BLTE) -19%. VectivBio VECT -14%...
Sidus Space (SIDU) +86% on NASA’s $3.5 Billion exploration extravehicular activity services contract. Evoke Pharma (EVOK) +68% on approval for nasal spray Gimoti being added to Florida's Medicaid program Boxed (BOXD) +33%. ACADIA Pharmaceuticals (ACAD) +29% as FDA posts ...
Shares of micro-cap company Evoke Pharma (NASDAQ:EVOK) soared ~70% to $3.45 in Wednesday premarket trading, after it said it had got approval for its Gimoti nasal spray treatment for diabetic gastroparesis to be added to the Florida Medicaid Preferred Drug List (PDL), effe...
SOLANA BEACH, Calif., June 15, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced that the Florida Me...
Evoke Pharma (NASDAQ:EVOK) has regained compliance with the Nasdaq minimum bid price continued listing requirement and the matter is now closed. As previously disclosed, in early May, the Company utilized its “at-the-market” program to raise proceeds of ~$7.1M, net of commission...
SOLANA BEACH, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced that it received wr...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Agrify Corporation (AGFY) rose 164.2% to $0.6658 on volume of 125,460,313 shares NVIDIA Corporation (NVDA) fell 2.9% to $122.88 on volume of 51,163,891 shares Crown Electrokinetics Corp. (CRKN) fell 0.3% to $0.04097 on volume of 44,45...
A look at the top 10 most actives in the United States Mustang Bio Inc. (MBIO) rose 141.4% to $0.3138 on volume of 161,736,322 shares ENDRA Life Sciences Inc. (NDRA) rose 13.7% to $0.117778 on volume of 79,058,950 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 27.2% to $0.1042 on volum...
Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024 Promoted former VP of Finance, Mark Kowieski to Chief Financial Officer SOLANA BEACH, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK)...